Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled magnesium sulfate added to Daolin nebulization for severe asthma attack in children
IRCT20251105067885N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of magnesium sulfate in asthma (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: respiratory rate, wheeze and 3 more. Started Nov 2025; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
asthma
Beyond the preview
Go deeper on IRCT20251105067885N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251105067885N1.